2025-07-11 - Analysis Report
Okay, here's an analysis of TG Therapeutics Inc. (TGTX) based on the data provided, formatted for a report and incorporating the requested analysis:

## TG Therapeutics Inc. (TGTX) Analysis

**Company Overview:** TG Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance Relative to S&P 500 (VOO)

*   **TGTX Cumulative Return:** 67.31%
*   **VOO Cumulative Return:** 96.17%
*   **Absolute Divergence:** -27.4%
*   **Relative Divergence:** 16.2% (Indicates TGTX is in the lower range of its historical divergence compared to VOO).

**Analysis:** TGTX has underperformed the S&P 500 over the analyzed period. The relative divergence suggests that while it's underperforming, it's near the lower end of its historical underperformance range compared to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR      | MDD   | Alpha     | Beta   | Cap(B) |
|------------|-----------|-------|-----------|--------|--------|
| 2015-2017  | -6.0%     | 56.5% | -35.0%    | -0.1   | 1.3    |
| 2016-2018  | -8.0%     | 58.6% | -26.0%    | 0.0    | 0.7    |
| 2017-2019  | 74.0%     | 58.6% | 44.0%     | 0.0    | 1.8    |
| 2018-2020  | 402.0%    | 58.6% | 382.0%    | -0.4   | 8.3    |
| 2019-2021  | 125.0%    | 63.5% | 76.0%     | -0.5   | 3.0    |
| 2020-2022  | -76.0%    | 70.4% | -78.0%    | -0.6   | 1.9    |
| 2021-2023  | -350.0%   | 70.4% | -368.0%   | -0.8   | 2.7    |
| 2022-2024  | 71.0%     | 73.1% | 45.0%     | -0.9   | 4.8    |
| 2023-2025  | 74.0%     | 73.1% | 26.0%     | 0.4   | 6.0    |

**Alpha, Beta Analysis:**

*   **CAGR Variability:**  The Compounded Annual Growth Rate (CAGR) shows significant volatility over different periods, ranging from -350.0% to 402.0%. This suggests a high-risk investment.
*   **Maximum Drawdown (MDD):** High MDD values (consistently above 50%) indicate substantial potential losses.
*   **Alpha:** The alpha is highly variable and frequently negative, suggesting underperformance relative to its benchmark (S&P 500) in many periods. However, there are periods of significant outperformance (e.g., 2018-2020).
*   **Beta:** The beta values fluctuate around 0, suggesting a weak correlation with the overall market.

### 2. Recent Stock Price Movements

*   **Current Price:** 37.67
*   **Previous Close:** 37.92
*   **Change:** -0.66
*   **5-Day Moving Average:** 37.2
*   **20-Day Moving Average:** 36.65
*   **60-Day Moving Average:** 37.17

**Analysis:** The stock price experienced a slight decrease in the most recent session. The 5-day moving average is above the 20-day moving average, which is above the 60-day moving average, suggesting a short-term upward trend.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 62.96
*   **PPO:** 0.37
*   **Hybrid Signal:** "cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.34)"
*   **Recent Relative Divergence Change (20-day):** +1.2 (Short-term Increase)
*   **Expected Return:** -239.5%

**Analysis:**

*   **MRI:** The MRI indicates a low-risk environment for the stock.
*   **RSI:** The RSI is approaching overbought territory (above 70), suggesting the stock may be due for a pullback.
*   **PPO:** The PPO is positive, indicating a potential upward trend.
*   **Hybrid Signal:** The hybrid signal suggests a cautious buying opportunity, with a small allocation of cash.
*   **Recent Relative Divergence Change:** The recent increase in relative divergence suggests a short-term strengthening of TGTX relative to its benchmark.
*   **Expected Return:** The expected return is significantly negative, suggesting that a long-term investment may not be favorable.
*   **Price Change:** The recent price change of -0.66 indicates a slight decrease, which could be a normal fluctuation. No significant volatility or major issues are immediately apparent based on this single data point.

### 4. Recent News & Significant Events

*   **[2025-07-11]** Major business developments, regulatory changes, or market events affecting TGTX.
*   **[2025-07-09]** Analysts discussing recent performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-10]** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-08]** Market experts highlight risks and opportunities, advising investors to monitor recent news and company announcements.

**Analysis:** Recent news points to potential catalysts driving stock volatility. Monitoring specific announcements and analyst reports will be crucial.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-09 | 0.03  | 0.12 B$   |
| 2024-11-07 | 0.03  | 0.08 B$   |
| 2024-08-09 | 0.05  | 0.07 B$   |
| 2024-05-06 | -0.07 | 0.06 B$   |
| 2025-05-09 | -0.07 | 0.06 B$   |

**Analysis:**

*   **EPS Trend:** The EPS has fluctuated, with recent quarters showing positive EPS but previous quarters showing negative values.
*   **Revenue Trend:** Revenue has generally increased over the quarters, indicating some growth in the company's sales.
*   **Comparison:** A notable observation is that the data includes a duplicate entry for 2025-05-09, which needs to be verified for accuracy.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.12B   | 87.14%        |
| 2024-12-31 | $0.11B   | 85.77%        |
| 2024-09-30 | $0.08B   | 88.86%        |
| 2024-06-30 | $0.07B   | 88.70%        |
| 2024-03-31 | $0.06B   | 91.43%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-03-31 | $0.24B   | 2.13%   |
| 2024-12-31 | $0.22B   | 10.49%  |
| 2024-09-30 | $0.19B   | 2.02%   |
| 2024-06-30 | $0.18B   | 3.87%   |
| 2024-03-31 | $0.16B   | -6.69%  |

**Analysis:**

*   **Revenue and Profitability:**  Revenue shows a steady increase over the recent quarters. The profit margins are exceptionally high, consistently above 85%, suggesting strong operational efficiency or pricing power.
*   **Capital and Profitability:**  Equity has been growing, indicating increased shareholder value.  ROE shows volatility but has improved in recent quarters, suggesting better utilization of equity to generate profits.

### 7. 종합 분석 (Overall Analysis)

TGTX presents a mixed picture. The company exhibits strong revenue growth and high profit margins, suggesting a potentially promising business model. However, its historical stock performance has lagged the S&P 500, with a history of high volatility and significant drawdowns. Recent news events point to potential catalysts, but also potential risks.

**Key Considerations:**

*   **Volatility:** TGTX is a volatile stock, as reflected in its wide-ranging CAGR, MDD, and Beta values.
*   **Growth Potential:** Recent revenue growth and high profit margins are encouraging signs.
*   **Technical Indicators:** Technical indicators suggest a cautious buying opportunity, but the RSI is approaching overbought levels.
*   **Risk Factors:** The negative expected return and high volatility make TGTX a high-risk investment.
*   **News & Events:**  Staying informed about company announcements, regulatory changes, and analyst opinions is crucial for making informed investment decisions.

**Recommendation:**

Given the high volatility, underperformance relative to the S&P 500, and negative expected return, a cautious approach is warranted. Investors should carefully weigh the potential risks and rewards before investing in TGTX and closely monitor news and events related to the company. The hybrid signal suggests a small, cautious buy, but only with a very small allocation and a clear understanding of the risks involved.
